499 related articles for article (PubMed ID: 27429584)
1. A Formulation Study of 5-Aminolevulinic Encapsulated in DPPC Liposomes in Melanoma Treatment.
Lin MW; Huang YB; Chen CL; Wu PC; Chou CY; Wu PC; Hung SY
Int J Med Sci; 2016; 13(7):483-9. PubMed ID: 27429584
[TBL] [Abstract][Full Text] [Related]
2. Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy.
Oh EK; Jin SE; Kim JK; Park JS; Park Y; Kim CK
Eur J Pharm Sci; 2011 Sep; 44(1-2):149-57. PubMed ID: 21782942
[TBL] [Abstract][Full Text] [Related]
3. Hypericin photodynamic activity in DPPC liposomes - part II: stability and application in melanoma B16-F10 cancer cells.
de Morais FAP; Gonçalves RS; Vilsinski BH; Lazarin-Bidóia D; Balbinot RB; Tsubone TM; Brunaldi K; Nakamura CV; Hioka N; Caetano W
Photochem Photobiol Sci; 2020 May; 19(5):620-630. PubMed ID: 32248218
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy for skin cancer: How to enhance drug penetration?
Champeau M; Vignoud S; Mortier L; Mordon S
J Photochem Photobiol B; 2019 Aug; 197():111544. PubMed ID: 31295716
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 5-aminolevulinic acid-encapsulated liposome versus ethosome for skin delivery for photodynamic therapy.
Fang YP; Tsai YH; Wu PC; Huang YB
Int J Pharm; 2008 May; 356(1-2):144-52. PubMed ID: 18325699
[TBL] [Abstract][Full Text] [Related]
6. Topical delivery of 5-aminolevulinic acid-encapsulated ethosomes in a hyperproliferative skin animal model using the CLSM technique to evaluate the penetration behavior.
Fang YP; Huang YB; Wu PC; Tsai YH
Eur J Pharm Biopharm; 2009 Nov; 73(3):391-8. PubMed ID: 19660544
[TBL] [Abstract][Full Text] [Related]
7. Liposomes in topical photodynamic therapy.
Dragicevic-Curic N; Fahr A
Expert Opin Drug Deliv; 2012 Aug; 9(8):1015-32. PubMed ID: 22731896
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the efficiency of 5-aminolevulinic acid-mediated photodynamic therapy using 5-fluorouracil on human melanoma cells.
Tahmasebi H; Khoshgard K; Sazgarnia A; Mostafaie A; Eivazi MT
Photodiagnosis Photodyn Ther; 2016 Mar; 13():297-302. PubMed ID: 26321747
[TBL] [Abstract][Full Text] [Related]
9. Comparation of liposomal formulations of ALA Undecanoyl ester for its use in photodynamic therapy.
Di Venosa G; Hermida L; Fukuda H; Defain MV; Rodriguez L; Mamone L; MacRobert A; Casas A; Batlle A
J Photochem Photobiol B; 2009 Aug; 96(2):152-8. PubMed ID: 19560367
[TBL] [Abstract][Full Text] [Related]
10. In vitro percutaneous absorption and in vivo protoporphyrin IX accumulation in skin and tumors after topical 5-aminolevulinic acid application with enhancement using an erbium:YAG laser.
Shen SC; Lee WR; Fang YP; Hu CH; Fang JY
J Pharm Sci; 2006 Apr; 95(4):929-38. PubMed ID: 16493590
[TBL] [Abstract][Full Text] [Related]
11. Application of 5-aminolevulinic acid and its derivatives for photodynamic therapy in vitro and in vivo.
Juzeniene A; Juzenas P; Moan J
Methods Mol Biol; 2010; 635():97-106. PubMed ID: 20552342
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
13. Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy.
Pierre MB; Ricci E; Tedesco AC; Bentley MV
Pharm Res; 2006 Feb; 23(2):360-6. PubMed ID: 16341572
[TBL] [Abstract][Full Text] [Related]
14. Improving in vitro photodynamic therapy through the development of a novel iron chelating aminolaevulinic acid prodrug.
Curnow A; Perry A; Wood M
Photodiagnosis Photodyn Ther; 2019 Mar; 25():157-165. PubMed ID: 30553949
[TBL] [Abstract][Full Text] [Related]
15. Size and surface charge effect of 5-aminolevulinic acid-containing liposomes on photodynamic therapy for cultivated cancer cells.
Kosobe T; Moriyama E; Tokuoka Y; Kawashima N
Drug Dev Ind Pharm; 2005 Aug; 31(7):623-9. PubMed ID: 16207609
[TBL] [Abstract][Full Text] [Related]
16. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
[TBL] [Abstract][Full Text] [Related]
17. Quinolone compounds enhance delta-aminolevulinic acid-induced accumulation of protoporphyrin IX and photosensitivity of tumour cells.
Ohgari Y; Miyata Y; Chau TT; Kitajima S; Adachi Y; Taketani S
J Biochem; 2011 Feb; 149(2):153-60. PubMed ID: 20961864
[TBL] [Abstract][Full Text] [Related]
18. Aminolevulinic acid derivatives and liposome delivery as strategies for improving 5-aminolevulinic acid-mediated photodynamic therapy.
Casas A; Batlle A
Curr Med Chem; 2006; 13(10):1157-68. PubMed ID: 16719777
[TBL] [Abstract][Full Text] [Related]
19. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery of 5-aminolevulinic acid by multifunctional hollow mesoporous silica nanoparticles for photodynamic skin cancer therapy.
Ma X; Qu Q; Zhao Y
ACS Appl Mater Interfaces; 2015 May; 7(20):10671-6. PubMed ID: 25974979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
